New Biomarker for Early Mesothelioma Diagnosis
Early treatment for mesothelioma is critical for overall survival. Researchers from Italy may have found a biomarker that can identify…
New Set of Biomarkers for Mesothelioma
A new set of biomarkers to diagnose mesothelioma has been identified by researchers in Italy. Mesothelioma is a rare type…
Mesothelioma and the Promising New Hippo Biomarker
A new review in Targeted Oncology looks at a promising new Hippo biomarker in malignant pleural mesothelioma. The new biomarker…
Biomarkers | Biopsy | Diagnosis | International | Prognosis
Serum IgG4: A New Biomarker for Mesothelioma Pleural Effusion
Egyptian scientists say a new biomarker is very good at identifying mesothelioma. Pleural effusions are pockets of excess fluid. They…
Asbestos | Biomarkers | Diagnosis | Europe
Identifying New MicroRNA Tumor Biomarkers for Mesothelioma
Identifying New MicroRNA Tumor Biomarkers for Mesothelioma Italian researchers have taken an important step forwards in what amounts to a…
Asbestos | Australia | Biomarkers | Genetics
Genomic Experts Report Most Complete Picture of Mesothelioma to Date
Australian and American genomic experts have completed a key step in improving the treatment of pleural mesothelioma. A new study…
Asbestos | Biomarkers | Biopsy | Diagnosis
New Tips for Diagnosing Malignant Peritoneal Mesothelioma
Malignant peritoneal mesothelioma is an aggressive cancer that often mimics other conditions. This can make it difficult to get a…
Biomarkers | Genetics | Research | Treatments
New Advancements in Personalized Medicine for Mesothelioma
Genomics is a new branch of medicine that involves using a patient’s genetic information to create personalized treatment. New research…
New Anti-Mesothelioma Antibody and Biomarker Discovered
Dr. Tsuji is working on discovering specific cancer antigens for malignant mesothelioma. A new study from the Gunma University of…
Hope for Mesothelioma Patients with Genetic Predisposition (Germline PVs) for Cancer
Malignant pleural mesothelioma is a tumor caused by asbestos exposure. Recently, the United States Food and Drug Administration approved immunotherapy…